Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Case

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Blood|May 1, 1982
Combination chemotherapy (M-2) protocol (BCNU, cyclophosphamide, vincristine, melphalan, and prednisone) for Waldenström macroglobulinemia: preliminary reportD C Case
Oncology|January 1, 1983
Long-term results of patients with advanced diffuse, non-Hodgkin's lymphoma treated with cyclophosphamide, doxorubicin, vincristine, prednisone and bleomycin (CHOP-Bleo)D C Case
Oncology|January 1, 1984
Comparison of M-2 protocol with COP in patients with nodular lymphomaD C Case
American Journal of Clinical Oncology|August 1, 1984
m-AMSA: phase II trial in advanced lymphoma and leukemiaD C Case
American Journal of Clinical Oncology|October 1, 1984
Combination chemotherapy for mycosis fungoides with cyclophosphamide, vincristine, methotrexate, and prednisoneD C Case
Blood|January 1, 1984
Therapy of essential thrombocythemia with thiotepa and chlorambucilD C Case
Cancer Genetics and Cytogenetics|June 1, 1984
Absence of a specific chromosomal marker in essential thrombocythemiaD C Case
Oncology|January 1, 1982
5-azacytidine in refractory acute leukemiaD C Case
Cancer Treatment Reports|November 1, 1983
Phase II study of aziridinylbenzoquinone in refractory lymphomaD C Case, D M Hayes
Environmental Technology|November 11, 2017
Nitrogen and phosphorus release from organic wastes and suitability as bio-based fertilizers in a circular economyS D C Case, L S Jensen
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Blood|May 1, 1982
Combination chemotherapy (M-2) protocol (BCNU, cyclophosphamide, vincristine, melphalan, and prednisone) for Waldenström macroglobulinemia: preliminary reportD C Case
Oncology|January 1, 1983
Long-term results of patients with advanced diffuse, non-Hodgkin's lymphoma treated with cyclophosphamide, doxorubicin, vincristine, prednisone and bleomycin (CHOP-Bleo)D C Case
Oncology|January 1, 1984
Comparison of M-2 protocol with COP in patients with nodular lymphomaD C Case
American Journal of Clinical Oncology|August 1, 1984
m-AMSA: phase II trial in advanced lymphoma and leukemiaD C Case
American Journal of Clinical Oncology|October 1, 1984
Combination chemotherapy for mycosis fungoides with cyclophosphamide, vincristine, methotrexate, and prednisoneD C Case
Blood|January 1, 1984
Therapy of essential thrombocythemia with thiotepa and chlorambucilD C Case
Cancer Genetics and Cytogenetics|June 1, 1984
Absence of a specific chromosomal marker in essential thrombocythemiaD C Case
Oncology|January 1, 1982
5-azacytidine in refractory acute leukemiaD C Case
Cancer Treatment Reports|November 1, 1983
Phase II study of aziridinylbenzoquinone in refractory lymphomaD C Case, D M Hayes
Environmental Technology|November 11, 2017
Nitrogen and phosphorus release from organic wastes and suitability as bio-based fertilizers in a circular economyS D C Case, L S Jensen
Pageof 5